Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
APGE
|
Carl Dambkowski
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,520 Reduced 1.37% |
$143,228
$40.69 p/Share
|
Feb 05
2025 |
|
ATEC
|
Patrick Miles
CEO |
SELL
Open market or private sale
|
Direct | 43,459 Reduced 0.71% |
$519,335
$11.95 p/Share
|
Feb 05
2025 |
|
ARLO
|
Matthew Blake Mcrae
CEO |
SELL
Open market or private sale
|
Direct | 59,316 Reduced 1.86% |
$677,981
$11.43 p/Share
|
Feb 05
2025 |
|
ARLO
|
Brian Busse
GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct | 11,475 Reduced 1.9% |
$131,159
$11.43 p/Share
|
Feb 05
2025 |
|
ZIP
|
Timothy G. Yarbrough
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 4,414 Reduced 0.0% |
$34,870
$7.9 p/Share
|
Feb 05
2025 |
|
SCWO
|
Yaacov Nagar |
SELL
Open market or private sale
|
Direct | 144,860 Reduced 0.4% |
$62,289
$0.43 p/Share
|
Feb 05
2025 |
|
QNST
|
Douglas Valenti
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.0% |
$250,200
$25.02 p/Share
|
Feb 05
2025 |
|
IMRA
|
Benjamin Hohl
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 7.14% |
$22,520
$22.52 p/Share
|
Feb 05
2025 |
|
PCOR
|
Kevin J O Connor |
SELL
Open market or private sale
|
Indirect | 6,410 Reduced 0.0% |
$495,685
$77.33 p/Share
|
Feb 05
2025 |
|
SFM
|
Jack Sinclair
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,915 Reduced 1.99% |
$488,379
$167.54 p/Share
|
Feb 05
2025 |
|
AKRO
|
Timothy Rolph
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 18,750 Reduced 9.92% |
$1,061,812
$56.63 p/Share
|
Feb 05
2025 |
|
ABT
|
Robert B Ford
CHAIRMAN AND CEO |
SELL
Open market or private sale
|
Direct | 285,388 Reduced 56.46% |
$37,434,343
$131.17 p/Share
|
Feb 05
2025 |
|
FCFS
|
R Douglas Orr
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 1.95% |
$226,700
$113.35 p/Share
|
Feb 05
2025 |
|
FCFS
|
R Douglas Orr
EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.0% |
$453,440
$113.36 p/Share
|
Feb 05
2025 |
|
TEM
|
James William Rogers
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 8,712 Reduced 3.79% |
$588,669
$67.57 p/Share
|
Feb 05
2025 |
|
TEM
|
Andrew Polovin
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 7,717 Reduced 3.15% |
$521,437
$67.57 p/Share
|
Feb 05
2025 |
|
TEM
|
Erik Phelps
EVP & Chief Admin & Legal Off |
SELL
Open market or private sale
|
Direct | 5,934 Reduced 2.69% |
$400,960
$67.57 p/Share
|
Feb 05
2025 |
|
TEM
|
Eric P Lefkofsky
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 74,485 Reduced 1.35% |
$5,032,206
$67.56 p/Share
|
Feb 05
2025 |
|
TEM
|
Ryan M Bartolucci
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 1,858 Reduced 3.25% |
$125,545
$67.57 p/Share
|
Feb 05
2025 |
|
SPSC
|
Kimberly K. Nelson
EVP & CFO |
SELL
Open market or private sale
|
Direct | 9,290 Reduced 5.94% |
$1,686,135
$181.5 p/Share
|
Feb 05
2025 |
|
RYTM
|
Jennifer Chien
EVP, Head of North America |
SELL
Open market or private sale
|
Direct | 3,066 Reduced 75.93% |
$187,056
$61.01 p/Share
|
Feb 05
2025 |
|
RELY
|
Matthew B. Oppenheimer
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 14,583 Reduced 0.33% |
$367,637
$25.21 p/Share
|
Feb 05
2025 |
|
OKTA
|
Jacques Frederic Kerrest
Director |
SELL
Open market or private sale
|
Direct | 65,000 Reduced 100.0% |
$6,337,500
$97.5 p/Share
|
Feb 05
2025 |
|
OKTA
|
Jacques Frederic Kerrest
Director |
SELL
Open market or private sale
|
Indirect | 9,999 Reduced 0.0% |
$974,902
$97.5 p/Share
|
Feb 05
2025 |
|
DSP
|
Larry Madden
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 14,284 Reduced 3.98% |
$330,246
$23.12 p/Share
|
Feb 05
2025 |
|
PHR
|
David Linetsky
SVP, Life Sciences |
SELL
Open market or private sale
|
Direct | 720 Reduced 0.31% |
$21,240
$29.5 p/Share
|
Feb 05
2025 |
|
USB
|
James L Chosy
Senior EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 21,451 Reduced 9.77% |
$1,022,140
$47.65 p/Share
|
Feb 05
2025 |
|
TYRA
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect | 5,401 Reduced 0.0% |
$74,317
$13.76 p/Share
|
Feb 05
2025 |
|
DGX
|
Mark E Delaney
SVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 403 Reduced 8.02% |
$66,212
$164.3 p/Share
|
Feb 05
2025 |
|
DGX
|
Vicky B Gregg
Director |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 6.9% |
$205,712
$164.57 p/Share
|
Feb 05
2025 |
|
EWTX
|
Behrad Derakhshan
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 37.26% |
$300,300
$30.03 p/Share
|
Feb 05
2025 |
|
EWTX
|
Kevin Koch
President and CEO |
SELL
Open market or private sale
|
Direct | 8,636 Reduced 37.36% |
$259,339
$30.03 p/Share
|
Feb 05
2025 |
|
EWTX
|
Alan J Russell
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 8,015 Reduced 35.03% |
$240,610
$30.02 p/Share
|
Feb 05
2025 |
|
FBP
|
Carlos Power
EVP |
SELL
Open market or private sale
|
Direct | 45,797 Reduced 19.71% |
$951,203
$20.77 p/Share
|
Feb 05
2025 |
|
DAL
|
Rahul D Samant
EVP & Chief Info Officer |
SELL
Open market or private sale
|
Direct | 17,970 Reduced 33.36% |
$1,241,367
$69.08 p/Share
|
Feb 05
2025 |
|
SGA
|
Edward K. Christian Trust |
SELL
Open market or private sale
|
Direct | 5,651 Reduced 0.59% |
$71,880
$12.72 p/Share
|
Feb 05
2025 |
|
LPLA
|
Matthew J Audette
President and CFO |
SELL
Open market or private sale
|
Direct | 28,777 Reduced 67.81% |
$10,486,626
$364.41 p/Share
|
Feb 05
2025 |
|
VCEL
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 8.59% |
$156,250
$62.5 p/Share
|
Feb 05
2025 |
|
VCEL
|
Jonathan Siegal
Principal Accounting Officer |
SELL
Open market or private sale
|
Direct | 1,092 Reduced 47.52% |
$67,693
$61.99 p/Share
|
Feb 05
2025 |
|
CSTL
|
Daniel Bradbury
Director |
SELL
Open market or private sale
|
Indirect | 7,867 Reduced 0.0% |
$221,613
$28.17 p/Share
|
Feb 05
2025 |
|
RXRX
|
Christopher Gibson
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 1.55% |
$153,600
$7.68 p/Share
|
Feb 05
2025 |
|
LC
|
Erin Selleck
Director |
SELL
Open market or private sale
|
Direct | 703 Reduced 0.97% |
$9,286
$13.21 p/Share
|
Feb 05
2025 |
|
DDOG
|
Amit Agarwal |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 11.33% |
$3,577,500
$143.1 p/Share
|
Feb 05
2025 |
|
EQR
|
Stephen E Sterrett
Director |
SELL
Open market or private sale
|
Direct | 2,101 Reduced 9.77% |
$151,713
$72.21 p/Share
|
Feb 05
2025 |
|
CHWY
|
Sumit Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 6,606 Reduced 0.0% |
$250,367
$37.9 p/Share
|
Feb 05
2025 |
|
CHWY
|
Sumit Singh
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 57,432 Reduced 6.14% |
$2,176,672
$37.9 p/Share
|
Feb 05
2025 |
|
CHWY
|
Satish Mehta
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 11,664 Reduced 2.75% |
$442,065
$37.9 p/Share
|
Feb 05
2025 |
|
PTC
|
Aaron C Von Staats
EVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 1,182 Reduced 5.66% |
$227,062
$192.1 p/Share
|
Feb 05
2025 |
|
PCVX
|
Mikhail Eydelman
SVP, GEN COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 15.05% |
$449,550
$89.91 p/Share
|
Feb 05
2025 |
|
CHWY
|
David Reeder
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 54,022 Reduced 13.01% |
$2,047,433
$37.9 p/Share
|
Feb 05
2025 |